Zilmax Plus Rumensin is a drug owned by INTERVET, INC. It is protected by 4 US drug patents filed from 2012 to 2030. Out of these, 1 patent is active and 3 patents have expired. Details of Zilmax Plus Rumensin’s patents and their expiration are given below.
About Zilmax Plus Rumensin
Zilmax Plus Rumensin is a drug
owned by INTERVET, INC.
Zilmax Plus Rumensin uses
Monensin, Zilpaterol as the active
ingredients.
Active Ingredient:
Zilmax Plus Rumensin uses
Monensin,
Zilpaterol
as the active ingredients.
Check out other Drugs and Companies using
Monensin, Zilpaterol ingredient.